Insights into the Regulation of the Glycine Transporter 1 (GlyT1)
深入了解甘氨酸转运蛋白 1 (GlyT1) 的调控
基本信息
- 批准号:7907776
- 负责人:
- 金额:$ 22.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-15 至 2012-07-31
- 项目状态:已结题
- 来源:
- 关键词:Biological AssayBrainBrain StemCell LineCell membraneCell surfaceCellsClinicalD AspartateDataDown-RegulationDrug Delivery SystemsEndocytosisEndothelial CellsFamilyFamily suidaeFunctional disorderGLYT1Glutamate AgonistGlutamate ReceptorGlutamatesGlycineGlycine ReceptorsGoalsHela CellsHippocampus (Brain)Immunofluorescence ImmunologicImmunoprecipitationLabelLaboratoriesLinkLiquid ChromatographyMass Spectrum AnalysisMembrane MicrodomainsMetabolicModelingMusN-Methyl-D-Aspartate ReceptorsNeurodegenerative DisordersNeurogliaNeuronsNeurotransmittersPathway interactionsPhosphorylationPhosphorylation SitePost-Translational Protein ProcessingProtein Kinase CProteinsRattusReceptor ActivationRegulationResearchRoleSchizophreniaSequence AnalysisSiteSite-Directed MutagenesisSmall Interfering RNASpinal CordStrychnineSymptomsSynapsesSystemTestingUbiquitinUbiquitinationWestern Blottingbasecitrate carriercognitive functiondopamine transporterdrug developmentglycine transporterinhibitor/antagonistinsightmembermonoaminenervous system disorderneurotransmissionpresynapticresearch studytandem mass spectrometrytrafficking
项目摘要
DESCRIPTION (provided by applicant): Glycine is the major inhibitory neurotransmitter in the brainstem and spinal cord, where it functions at specific strychnine-sensitive glycine receptors. In addition, glycine participates in excitatory neurotransmission as an essential co-agonist of glutamate at N-methyl-D-aspartate (NMDA) receptor containing synapses; therefore, NMDA receptor activation is tightly modulated by the activity of the plasma membrane glycine transporter 1 (GlyT1) present in presynaptic neurons and neighboring glial cells. Altered numbers of functional NMDA receptors have been suggested to underlie some of the symptoms in schizophrenia, primarily in cognitive functions. The GlyT1 has been the main target for drug development in schizophrenia; however, how the transporter is regulated remains poorly understood. It is known for several members of the monoamine transporter family that transport activity is linked to activation of Protein Kinase C (PKC); however, the mechanism of regulation is controversial or unknown in the brain. Given the strength of clinical and pharmacological data suggesting glutamate receptor dysfunction in schizophrenia and the role of the glycine transporter as a potential drug target, in this study our goal is to characterize the regulatory mechanism of the GlyT1 using two expression systems: (a) mouse GlyTIa expressed in model cell lines (HeLa and Porcine Aortic Endothelial cells, PAE) and (b) endogenous GlyT1 in primary cultures from rat hippocampus. Based on preliminary data from our laboratory that suggest enhanced PKC-dependent ubiquitination and endocytosis obtained by expressing GlyT1 in HeLa cells, we hypothesize that PKC activation results in GlyT1 ubiquitination and down-regulation in the brain, contributing to the regulation of the glycine transporter. This research will offer new potential pharmacological targets to treat neurological disorders, such as schizophrenia.
描述(由申请人提供):甘氨酸是脑干和脊髓中的主要抑制性神经递质,在特定的肾上腺素敏感甘氨酸受体下起作用。此外,甘氨酸也参与兴奋性神经传递,作为N-甲基-D-天冬氨酸(NMDA)受体的谷氨酸的必不可少的共同受体,其中含有突触。因此,NMDA受体激活受到了突触前神经元和邻近神经胶质细胞中存在的质膜1(GLYT1)的活性严格调节。已经提出了功能性NMDA受体数量的改变,这是精神分裂症中一些症状的基础,主要是在认知功能方面。 Glyt1一直是精神分裂症药物开发的主要靶标。但是,如何调节转运蛋白仍然了解得很糟糕。它以单胺转运蛋白家族的几个成员而闻名,即转运活性与蛋白激酶C(PKC)的激活有关。但是,调节机制在大脑中是有争议的或未知的。 Given the strength of clinical and pharmacological data suggesting glutamate receptor dysfunction in schizophrenia and the role of the glycine transporter as a potential drug target, in this study our goal is to characterize the regulatory mechanism of the GlyT1 using two expression systems: (a) mouse GlyTIa expressed in model cell lines (HeLa and Porcine Aortic Endothelial cells, PAE) and (b) endogenous GlyT1在大鼠海马的一级培养物中。基于我们实验室的初步数据表明,通过在HELA细胞中表达Glyt1获得的PKC依赖性泛素化和内吞作用增强,我们假设PKC激活导致Glyt1泛素化和大脑的下调,从而有助于调节甘霉素转运器。这项研究将为治疗神经系统疾病(例如精神分裂症)提供新的潜在药理靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manuel Miranda-Arango其他文献
Manuel Miranda-Arango的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manuel Miranda-Arango', 18)}}的其他基金
Novel Glycinergic Circuitry in the Basal Ganglia
基底神经节中的新型甘氨酸能回路
- 批准号:
10158553 - 财政年份:2020
- 资助金额:
$ 22.2万 - 项目类别:
Novel Glycinergic Circuitry in the Basal Ganglia
基底神经节中的新型甘氨酸能回路
- 批准号:
10600036 - 财政年份:2020
- 资助金额:
$ 22.2万 - 项目类别:
Novel Glycinergic Circuitry in the Basal Ganglia
基底神经节中的新型甘氨酸能回路
- 批准号:
10381670 - 财政年份:2020
- 资助金额:
$ 22.2万 - 项目类别:
Insights into the Regulation of the Glycine Transporter 1 (GlyT1)
深入了解甘氨酸转运蛋白 1 (GlyT1) 的调控
- 批准号:
8118106 - 财政年份:2008
- 资助金额:
$ 22.2万 - 项目类别:
Insights into the Regulation of the Glycine Transporter 1 (GlyT1)
深入了解甘氨酸转运蛋白 1 (GlyT1) 的调控
- 批准号:
7499296 - 财政年份:2008
- 资助金额:
$ 22.2万 - 项目类别:
Insights into the Regulation of the Glycine Transporter 1 (GlyT1)
深入了解甘氨酸转运蛋白 1 (GlyT1) 的调控
- 批准号:
7687349 - 财政年份:2008
- 资助金额:
$ 22.2万 - 项目类别:
相似国自然基金
靶向小胶质细胞的仿生甘草酸纳米颗粒构建及作用机制研究:脓毒症相关性脑病的治疗新策略
- 批准号:82302422
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
HMGB1/TLR4/Cathepsin B途径介导的小胶质细胞焦亡在新生大鼠缺氧缺血脑病中的作用与机制
- 批准号:82371712
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于脑-脊髓-视神经MRI影像特征的神经免疫疾病影像亚型及其分子生物学机制的多组学研究
- 批准号:82330057
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering the Functional Effects of Neurotrophins in the Auditory Brainstem
揭示神经营养素对听觉脑干的功能影响
- 批准号:
10823506 - 财政年份:2024
- 资助金额:
$ 22.2万 - 项目类别:
Functional characterization of schizophrenia rare variants using genetically engineered human iPSCs
使用基因工程人类 iPSC 进行精神分裂症罕见变异的功能表征
- 批准号:
10554598 - 财政年份:2023
- 资助金额:
$ 22.2万 - 项目类别:
Mechanisms of Juvenile Neurogenesis and Post-Stroke Recovery: Determining the Role of Age-Associated Neuroimmune Interactions
青少年神经发生和中风后恢复的机制:确定与年龄相关的神经免疫相互作用的作用
- 批准号:
10637874 - 财政年份:2023
- 资助金额:
$ 22.2万 - 项目类别:
Intratumor heterogeneity in BRCA1-mutated breast cancer metastasis
BRCA1 突变乳腺癌转移的瘤内异质性
- 批准号:
10680318 - 财政年份:2023
- 资助金额:
$ 22.2万 - 项目类别:
Identifying the role of notch3 in brain pericyte function in health and Alzheimer's disease
确定 notch3 在健康和阿尔茨海默病中大脑周细胞功能中的作用
- 批准号:
10679198 - 财政年份:2023
- 资助金额:
$ 22.2万 - 项目类别: